ABEONA THERAPEUTICS INC.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $5.8 | — | $3.5 | $1.4 | $3.0 |
| Operating income | -$89.4 | -$64.2 | -$47.1 | -$50.9 | -$89.8 |
| Net income | $71.2 | -$63.7 | -$54.2 | -$39.7 | -$84.9 |
| Balance Sheet | |||||
| Total debt | $20.0 | $20.0 | — | — | — |
| Cash Flow Statement | |||||
| Free cash flow | -$84.3 | -$58.5 | -$37.3 | -$43.6 | -$69.8 |
| Share repurchases | — | — | — | $25.0 | — |
Shares outstanding 57.2M · Free float 56.3%
Annual filing data through FY ended December 31, 2025; float as of September 19, 2026.